447 related articles for article (PubMed ID: 19881541)
1. Wnt signaling activation and mammary gland hyperplasia in MMTV-LRP6 transgenic mice: implication for breast cancer tumorigenesis.
Zhang J; Li Y; Liu Q; Lu W; Bu G
Oncogene; 2010 Jan; 29(4):539-49. PubMed ID: 19881541
[TBL] [Abstract][Full Text] [Related]
2. SOX9 regulates low density lipoprotein receptor-related protein 6 (LRP6) and T-cell factor 4 (TCF4) expression and Wnt/β-catenin activation in breast cancer.
Wang H; He L; Ma F; Regan MM; Balk SP; Richardson AL; Yuan X
J Biol Chem; 2013 Mar; 288(9):6478-87. PubMed ID: 23306204
[TBL] [Abstract][Full Text] [Related]
3. Loss of Limb-Bud-and-Heart (LBH) attenuates mammary hyperplasia and tumor development in MMTV-Wnt1 transgenic mice.
Ashad-Bishop K; Garikapati K; Lindley LE; Jorda M; Briegel KJ
Biochem Biophys Res Commun; 2019 Jan; 508(2):536-542. PubMed ID: 30509497
[TBL] [Abstract][Full Text] [Related]
4. Cooperative signaling between Wnt1 and integrin-linked kinase induces accelerated breast tumor development.
Oloumi A; Maidan M; Lock FE; Tearle H; McKinney S; Muller WJ; Aparicio SA; Dedhar S
Breast Cancer Res; 2010; 12(3):R38. PubMed ID: 20565980
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of tumorigenesis driven by different Wnt proteins requires blockade of distinct ligand-binding regions by LRP6 antibodies.
Ettenberg SA; Charlat O; Daley MP; Liu S; Vincent KJ; Stuart DD; Schuller AG; Yuan J; Ospina B; Green J; Yu Q; Walsh R; Li S; Schmitz R; Heine H; Bilic S; Ostrom L; Mosher R; Hartlepp KF; Zhu Z; Fawell S; Yao YM; Stover D; Finan PM; Porter JA; Sellers WR; Klagge IM; Cong F
Proc Natl Acad Sci U S A; 2010 Aug; 107(35):15473-8. PubMed ID: 20713706
[TBL] [Abstract][Full Text] [Related]
6. The Wnt co-receptor Lrp6 is required for normal mouse mammary gland development.
Lindvall C; Zylstra CR; Evans N; West RA; Dykema K; Furge KA; Williams BO
PLoS One; 2009 Jun; 4(6):e5813. PubMed ID: 19503830
[TBL] [Abstract][Full Text] [Related]
7. Wnt5a suppresses tumor formation and redirects tumor phenotype in MMTV-Wnt1 tumors.
Easter SL; Mitchell EH; Baxley SE; Desmond R; Frost AR; Serra R
PLoS One; 2014; 9(11):e113247. PubMed ID: 25401739
[TBL] [Abstract][Full Text] [Related]
8. Protein kinase CK2 in mammary gland tumorigenesis.
Landesman-Bollag E; Romieu-Mourez R; Song DH; Sonenshein GE; Cardiff RD; Seldin DC
Oncogene; 2001 May; 20(25):3247-57. PubMed ID: 11423974
[TBL] [Abstract][Full Text] [Related]
9. Both LRP5 and LRP6 receptors are required to respond to physiological Wnt ligands in mammary epithelial cells and fibroblasts.
Goel S; Chin EN; Fakhraldeen SA; Berry SM; Beebe DJ; Alexander CM
J Biol Chem; 2012 May; 287(20):16454-66. PubMed ID: 22433869
[TBL] [Abstract][Full Text] [Related]
10. Changes in gene expression during the development of mammary tumors in MMTV-Wnt-1 transgenic mice.
Huang S; Li Y; Chen Y; Podsypanina K; Chamorro M; Olshen AB; Desai KV; Tann A; Petersen D; Green JE; Varmus HE
Genome Biol; 2005; 6(10):R84. PubMed ID: 16207355
[TBL] [Abstract][Full Text] [Related]
11. LRP6 overexpression defines a class of breast cancer subtype and is a target for therapy.
Liu CC; Prior J; Piwnica-Worms D; Bu G
Proc Natl Acad Sci U S A; 2010 Mar; 107(11):5136-41. PubMed ID: 20194742
[TBL] [Abstract][Full Text] [Related]
12. Integrin-interacting protein Kindlin-2 induces mammary tumors in transgenic mice.
Li B; Chi X; Song J; Tang Y; Du J; He X; Sun X; Bi Z; Wang Y; Zhan J; Zhang H
Sci China Life Sci; 2019 Feb; 62(2):225-234. PubMed ID: 30460471
[TBL] [Abstract][Full Text] [Related]
13. A mouse mammary tumor virus-Wnt-1 transgene induces mammary gland hyperplasia and tumorigenesis in mice lacking estrogen receptor-alpha.
Bocchinfuso WP; Hively WP; Couse JF; Varmus HE; Korach KS
Cancer Res; 1999 Apr; 59(8):1869-76. PubMed ID: 10213494
[TBL] [Abstract][Full Text] [Related]
14. Wnt signaling, stem cells, and the cellular origin of breast cancer.
Lindvall C; Bu W; Williams BO; Li Y
Stem Cell Rev; 2007 Jun; 3(2):157-68. PubMed ID: 17873348
[TBL] [Abstract][Full Text] [Related]
15. Chromatin effector Pygo2 regulates mammary tumor initiation and heterogeneity in MMTV-Wnt1 mice.
Watanabe K; Fallahi M; Dai X
Oncogene; 2014 Jan; 33(5):632-42. PubMed ID: 23334328
[TBL] [Abstract][Full Text] [Related]
16. Constitutive overexpression of Id-1 in mammary glands of transgenic mice results in precocious and increased formation of terminal end buds, enhanced alveologenesis, delayed involution.
Shin DH; Jang SH; Kang BC; Kim HJ; Oh SH; Kong G
J Cell Physiol; 2011 May; 226(5):1340-52. PubMed ID: 20945346
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of the tumor suppressor gene phosphatase and tensin homologue partially inhibits wnt-1-induced mammary tumorigenesis.
Zhao H; Cui Y; Dupont J; Sun H; Hennighausen L; Yakar S
Cancer Res; 2005 Aug; 65(15):6864-73. PubMed ID: 16061670
[TBL] [Abstract][Full Text] [Related]
18. P190B RhoGAP has pro-tumorigenic functions during MMTV-Neu mammary tumorigenesis and metastasis.
McHenry PR; Sears JC; Herrick MP; Chang P; Heckman-Stoddard BM; Rybarczyk M; Chodosh LA; Gunther EJ; Hilsenbeck SG; Rosen JM; Vargo-Gogola T
Breast Cancer Res; 2010; 12(5):R73. PubMed ID: 20860838
[TBL] [Abstract][Full Text] [Related]
19. In vivo analysis of mammary and non-mammary tumorigenesis in MMTV-cyclin D1 transgenic mice deficient in p53.
Hosokawa Y; Papanikolaou A; Cardiff RD; Yoshimoto K; Bernstein M; Wang TC; Schmidt EV; Arnold A
Transgenic Res; 2001 Oct; 10(5):471-8. PubMed ID: 11708657
[TBL] [Abstract][Full Text] [Related]
20. Conditional deletion of β-catenin in mammary epithelial cells of Ron receptor, Mst1r, overexpressing mice alters mammary tumorigenesis.
Wagh PK; Zinser GM; Gray JK; Shrestha A; Waltz SE
Endocrinology; 2012 Jun; 153(6):2735-46. PubMed ID: 22474186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]